Rodrigo Dienstmann_MD_MBA

MD/MBA, Medical Director Oncoclínicas Precision Medicine, Oncology Data Scientist at VHIO Digital Health. Views my own. Advisory/speaker Roche and others.

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

#ESMOAI25 discussion on #HealthAI agents that every oncologist will confront:
✅ performance as co-pilots
✅ accountability and explainability
✅ architecture flexibility for continuous learning
✅ how to boost productivity in the real-world
@myESMO to work on guidance🔜

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

Oncology education in the age of #HealthAI.
Literacy discussion at #ESMOAI25 congress:
➡️Check out @myESMO RWD and Digital Oncology Journal "AI Special Issue" - prepare doctors to AI-augmented care❗️ https://t.co/yWYH9bMNV7

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

#ESMOAI25 🔥topic: AI agents can transform Tumor Boards with #HealthAI
1⃣ Tools that orchestrate information retrieval
2⃣ Multimodal data integration
3⃣ Decision-support
@myESMO RWD and Digital Oncology Journal https://t.co/o8SQzPwre7

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

#HealthAI LLMs are robustly matching oncology patients to trials AND screening trials for individual patients. Check out #ESMOAI25 abstracts published at @myESMO RWD and Digital Oncology Journal (https://t.co/o8SQzPwZ3F).
✅ >85% accuracy
✅ need fine-tuning + prompt engineering

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

#ESMOAI25 session on Clinical trials and #HealthAI highlights:
1⃣radiology and pathology AI biomarkers undergoing trial validation
2⃣AI to refine inclusion criteria and simulate control arms with RWD have huge potential
Publish at @myESMO RWD&DO journal (https://t.co/o8SQzPwZ3F)

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

“All disease begins in the gut”

#ESMOGI24 @myESMO lecture on #microbiome regulating immune system by Laurence Zitvogel

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

#ESMOGI24 day 2 take-home message:

🤔 we cannot assume that young patients with hard-to-treat GI cancers do not deserve discussions on fertility preservation‼️

Excellent closing session

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

⚠️Do not miss @MyriamChalabi perspective on immunotherapies in MSS #colorectalcancer

[ESMO - Eur. Oncology @myESMO]

#ESMOGI24: Do recent advances offer hope for mismatch repair-proficient and MSS #CRC pts who have a lower mutational burden and have historically been less responsive to immunotherapy?
Read the opinion by @MyriamChalabi on #ESMODailyReporter to find out
📌https://t.co/s9vDxfCXG2

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

Keynote lecture by @MyriamChalabi at #ESMOGI24

☑️ is there room for #immunotherapy in MSS colorectal cancer❓

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

@fasc1nate 1

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

Honored with the Brazilian Society of Medical Oncology Prize of Translational Research. Gives me energy to continue fighting for better patient care and outcomes! Thanks @ffnava for the continues support! @VHIO @oncoclinicas

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

➡️Future of AI in cancer care
@ASCOPost article linking ESMO GROW (#RWD reporting standards) with #AI applied to #oncology and the new @myESMO RWD and Digital Oncology Journal
@OncologyAdvance

https://t.co/3b1VrgQxVb

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

➡️Guidelines for RWD reporting
➡️ChatGPT in medical research
➡️ESMO RWD & Digital Oncology vision and mission

https://t.co/o8SQzPwre7

DO NOT MISS THE FIRST ONLINE PAPERS❗️

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

This work represents a milestone for #RWD studies in #oncology !
➡️ Access ESMO RWD and Digital Oncology content here: https://t.co/o8SQzPwre7
@OncologyAdvance @myESMO

[ESMO - Eur. Oncology @myESMO]

ESMO announces the publication of ESMO-GROW, the first oncology-specific reporting guidance for #RWEstudies, representing a key step forward to increase quality standards and harmonised interpretations in RWD publications in #oncology.
👉https://t.co/nWUFGPvANH

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

➡️The future of #RWD research is now!
@myESMO daily reporter editorial presenting ESMO Real-World Data and Digital Oncology Journal.
Proud to be part of this journey❗️
➡️Go-to journal for health technology innovation in oncology care!
https://t.co/wrCDMsnilZ

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

▶️ Go-to journal for #RWD and #digitalhealth research in oncology!

https://t.co/pSUvDOWART

@flatironhealth @GroupeUnicancer @BCPlatforms @TriNetX @OwkinScience @PromptlyHealth @IQVIA_global @GetReal_Inst @aetioninc @ProstatePioneer @HarmonynetEU @BD4BO @RWE4Decisions @idea4rc

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

@myESMO channel to educate the oncology community on the transformation of care with RWE and digital technologies that we can trust and understand✅ Happy to be part of the journey❗️

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

@pablomartirod Oleeeee!!!!

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

@DrAngelaLamarca @myESMO Felicidades! Well deserved, your dedication is absolut!

[Rodrigo Dienstmann_MD_MBA @rdienstmann]

@aftimosp @mybsmo @E_de_Azambuja Congratulations @E_de_Azambuja ! Always proud of you!